CPRIT Awards RBM $3M to Expand OncologyMAP Biomarker Panel; Launch Targeted for Fall
July 16, 2010
CPRIT Awards RBM $3M to Expand OncologyMAP Biomarker Panel; Launch Targeted for Fall
The award will enable Rules-Based Medicine to add to its OncologyMAP panel immunoassays for 150 to 180 blood-based protein biomarkers associated with cancer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Myriad to Enter Proteomics Market with $80M Purchase of Rules-Based Medicine
April 29, 2011 / ProteoMonitor - Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's
December 10, 2010 / ProteoMonitor - Rules-Based Medicine Withdraws IPO
November 12, 2010 / ProteoMonitor - TARC Team Uses RBM's DiscoveryMAP Platform to Develop Alzheimer's Protein-Biomarker Test
September 17, 2010 / ProteoMonitor - ADNI Researchers and Industry Partners Developing Proteomic Profiles to Track Alzheimer's Disease
June 11, 2010 / ProteoMonitor